EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI‐RADS v2.1 Score ≥3

Mingjian Ruan, Yi Liu, Kaifeng Yao, Kexin Wang, Yu Fan, Shiliang Wu iD, Xiaoying Wang iD

Journal of Magnetic Resonance Imaging · 2024

DOI: 10.1002/jmri.29275 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Mingjian Ruan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Machine Learning, Prostate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding (Interdepartmental Clinical Research Project of Peking University First Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For patients with PI‐RADS v2.1 ≥ 3, prostate biopsy is strongly recommended. Due to the unsatisfactory positive rate of biopsy, improvements in clinically significant prostate cancer (csPCa) risk assessments are required.

Purpose

To develop and validate machine learning (ML) models based on clinical and imaging parameters for csPCa detection in patients with PI‐RADS v2.1 ≥ 3. Study Type Retrospective. Subjects One thousand eighty‐three patients with PI‐RADS v2.1 ≥ 3, randomly split into training (70%, N = 759) and validation (30%, N = 324) datasets, and 147 patients enrolled prospectively for testing. Field Strength/Sequence 3.0 T scanners/T2‐weighted fast spin echo sequence and DWI with diffusion‐weighted single‐shot gradient echo planar imaging sequence. Assessment The factors evaluated for csPCa detection were age, prostate specific antigen, prostate volume, and the diameter and location of the index lesion, PI‐RADSv2.1. Five ML models for csPCa detection were developed: logistic regression (LR), extreme gradient boosting, random forest (RF), decision tree, and support vector machines. The csPCa was defined as Gleason grade ≥2. Statistical Tests Univariable and multivariable LR analyses to identify parameters associated with csPCa. Area under the receiver operating characteristic curve (AUC), Brier score, and DeLong test were used to assess and compare the csPCa diagnostic performance with the LR model. The significance level was defined as 0.05.

Results

The RF model exhibited the highest AUC (0.880–0.904) and lowest Brier score (0.125–0.133) among the ML models in the validation and testing cohorts, however, there was no difference when compared to the LR model ( P = 0.453 and 0.548). The sensitivity and negative predictive values in the validation and testing cohorts were 93.8%–97.6% and 82.7%–95.1%, respectively, at a threshold of 0.450 (99% sensitivity of the RF model). Data Conclusion The RF model might help for assessing the risk of csPCa and preventing overdiagnosis and unnecessary biopsy for men with PI‐RADSv2.1 ≥ 3. Evidence Level 3 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMachine LearningProstateHumansMaleAgedMiddle AgedRetrospective StudiesReproducibility of ResultsProstate-Specific AntigenMagnetic Resonance ImagingBiopsyImage Interpretation, Computer-AssistedRisk AssessmentEcho-Planar ImagingDiffusion Magnetic Resonance ImagingROC Curve

Stichwörter der Autor:innen

machine learningprostate biopsyprostate cancerrandom forest

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Peking University First Hospital, Beijing, China.
  • Institute of Urology, Peking University, Beijing, China.
  • National Urological Cancer Center of China, Beijing, China.
  • School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Drug Clinical Trial Institution, Peking University First Hospital, Beijing, China.
  • Department of Radiology, Peking University First Hospital, Beijing, China.

ORCID-Profile: Shiliang Wu, Xiaoying Wang

Förderung

  • National High Level Hospital Clinical Research Funding (Interdepartmental Clinical Research Project of Peking University First Hospital)

Zitieren

APA

Ruan, M., Liu, Y., Yao, K., Wang, K., Fan, Y., Wu, S., & Wang, X. (2024). Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI‐RADS v2.1 Score ≥3. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29275

Vancouver

Ruan M, Liu Y, Yao K, Wang K, Fan Y, Wu S, et al. Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI‐RADS v2.1 Score ≥3. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29275

BibTeX
@article{Ruan2024,
  author = {Ruan, Mingjian and Liu, Yi and Yao, Kaifeng and Wang, Kexin and Fan, Yu and Wu, Shiliang and Wang, Xiaoying},
  title = {Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI‐RADS v2.1 Score ≥3},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1002/jmri.29275}
}
Kostenlos starten →